Aalberts handed in an in line with our and consensus expectations set of 3Q25 results. Management though adjusted the 2025 EBITA margin guidance towards the lower end of the prior range of between 13% and 14%. We lower our adjusted EBITA margin estimate from 13.5% to 13.0% and our 2025F EPS is cut by 1.1%. Ongoing difficult macro-economic conditions, especially in Europe, hamper a volume-driven recovery in the Building and Industrial division. The Semicon division is facing an easier YoY compari...
A director at UCB SA bought 70 shares at 250.000EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing C...
Aalberts: 3Q in line, FY margin now low end of guidance. Acomo: Going from strength to strength. Ahold Delhaize: New $860m distribution centre for Food Lion. Azelis: Weak 3Q25 as broadly expected, CFO to step down. Barco: Press release ahead of CMD. BE Semiconductor Industries: 3Q25 Results – Delivered on order intake. Econocom: 3Q25 organic growth down to c.3.4%, full year growth guidance confirmed. Heineken: EverGreen 2030. Kinepolis: Weak 3Q25 as expected, with Netherlands at ...
Over 3Q25 Aalberts' topline came in above expectations organically declining by -1.9%. Topline stood at €773m compared to our €747mE and consensus of €754mE. Adjusted EBITA of €96m was in line with our €97mE and CSS of €97mE. Overall EBITA margin was a bit softer at 12.5% (vs. 12.8% CSS, 13% KBC) and down from 13.7% in 3Q24. The company is now guiding for a fully year EBITA margin of around 13% down from a range of 13-14% issued at the 2H25 release. KBC and CSS are currently banking on 13.5% mar...
Hybrid Software Group published their limited 3Q trading update. After a tough 1H25, the company has turned the page with a significant uptick in sales and, more importantly, very strong margins. At these levels HYSG is well on track to beat our FY operating & net result estimates. We keep our TP on €5.0 for now and comfortably reiterate our Buy recommendation.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.